Literature DB >> 2181018

Expression of HLA ABC and DR antigens in thyroid neoplasia and correlation with mononuclear leukocyte infiltration.

M E Fisfalen1, W A Franklin, L J DeGroot, R S Cajulis, K Soltani, M Ryan, N Jones.   

Abstract

The rejection of tumor cells by the immune system depends on the production of tumor-associated antigens and the expression of HLA antigens on these cells. We therefore studied the expression of HLA ABC and DR antigens in malignant and benign thyroid disorders and correlated it with the types and extent of mononuclear cell infiltration. In the normal thyroid, HLA ABC expression was weak and focal, while it was diffusely present in benign disorders and in most but not all malignancies. HLA DR antigens, while absent or infrequently expressed in normal thyroid, were strongly but often focally expressed in all cases of autoimmune thyroid disease (AITD), as well as in most cases of malignant tumors and benign epithelium surrounding these tumors, and colloid nodule disease. There was a T cell predominance in all disorders, and the CD4+/CD8+ ratio was greater than 1 in most benign and malignant specimens. There was a direct correlation between the high expression of HLA antigens and dense inflammatory infiltration in AITD but not in most tumor specimens. Lack of such correlation suggests that the expression of HLA antigens is an autonomous event in tumors, independent of cellular infiltrate.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2181018     DOI: 10.1007/BF03348579

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  42 in total

Review 1.  Antigen presentation pathways to class I and class II MHC-restricted T lymphocytes.

Authors:  T J Braciale; L A Morrison; M T Sweetser; J Sambrook; M J Gething; V L Braciale
Journal:  Immunol Rev       Date:  1987-08       Impact factor: 12.988

2.  Occurrence of thyrocyte HLA class II expression in a wide variety of thyroid diseases: relationship with lymphocytic infiltration and thyroid autoantibodies.

Authors:  A Lucas-Martin; M Foz-Sala; I Todd; G F Bottazzo; R Pujol-Borrell
Journal:  J Clin Endocrinol Metab       Date:  1988-02       Impact factor: 5.958

3.  In situ immune complexes, lymphocyte subpopulations, and HLA-DR-positive epithelial cells in Hashimoto thyroiditis.

Authors:  G Aichinger; H Fill; G Wick
Journal:  Lab Invest       Date:  1985-02       Impact factor: 5.662

Review 4.  Ia antigens as restriction molecules in Ir-gene controlled T-cell proliferation.

Authors:  Z A Nagy; C N Baxevanis; N Ishii; J Klein
Journal:  Immunol Rev       Date:  1981       Impact factor: 12.988

5.  Expression of Ia-like antigens in normal human nonlymphoid tissues.

Authors:  P G Natali; C De Martino; V Quaranta; M R Nicotra; F Frezza; M A Pellegrino; S Ferrone
Journal:  Transplantation       Date:  1981-01       Impact factor: 4.939

6.  The detailed distribution of HLA-A, B, C antigens in normal human organs.

Authors:  A S Daar; S V Fuggle; J W Fabre; A Ting; P J Morris
Journal:  Transplantation       Date:  1984-09       Impact factor: 4.939

7.  Expression of the myc cellular proto-oncogene in human thyroid tissue.

Authors:  S Yamashita; J Ong; J A Fagin; S Melmed
Journal:  J Clin Endocrinol Metab       Date:  1986-11       Impact factor: 5.958

8.  Expression of HLA-DR antigens by colonic epithelium in inflammatory bowel disease.

Authors:  W S Selby; G Janossy; D Y Mason; D P Jewell
Journal:  Clin Exp Immunol       Date:  1983-09       Impact factor: 4.330

9.  Antigenic heterogeneity of skin tumors of nonmelanocyte origin: analysis with monoclonal antibodies to tumor-associated antigens and to histocompatibility antigens.

Authors:  P G Natali; M Viora; M R Nicotra; P Giacomini; A Bigotti; S Ferrone
Journal:  J Natl Cancer Inst       Date:  1983-09       Impact factor: 13.506

10.  Loss of HLA-A,B,C and de novo expression of HLA-D in colorectal cancer.

Authors:  F Momburg; T Degener; E Bacchus; G Moldenhauer; G J Hämmerling; P Möller
Journal:  Int J Cancer       Date:  1986-02-15       Impact factor: 7.396

View more
  2 in total

1.  HLA-D Antigen Expression and Langerhans' Cell Infiltrates in Thyroid Tumors.

Authors:  Simon L. Raphael; Sylvia L. Asa
Journal:  Endocr Pathol       Date:  1995       Impact factor: 3.943

2.  Therapeutic applications of the selective high affinity ligand drug SH7139 extend beyond non-Hodgkin's lymphoma to many other types of solid cancers.

Authors:  Rod Balhorn; Monique Cosman Balhorn
Journal:  Oncotarget       Date:  2020-09-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.